Posts tagged “Intersouth”
Venture-backed Cempra explores funding options
The Chapel Hill firm is developing potential antibacterial drugs to combat superbugs. Will it seek more venture funding or a partnership with a bigger pharmaceutical firm?
Semiconductor firm HexaTech closes on $3.1M, wants another $1.1M
The venture capital backed startup, which has been funded locally by Intersouth Partners and NCIDEA, is commercializing technology developed at NC State.
Argos Therapeutics files for $86M initial public offering
The Durham-based biopharmaceutical firm focuses on individualized therapies targeting cancer, HIV and infectious diseases. Its investors include Intersouth Partners and Aurora Funds.
Argos process
Semprius to build plant, create 256 jobs in Henderson
The Durham-based semiconductor startup will receive millions in local and state tax incentives if jobs targets are met.
Durham semiconductor firm reportedly picks NC for new plant
Gov. Bev Perdue is to make a new jobs announcement Tuesday morning in Henderson. Semprius, which is backed by the CIA, could be the builder.
Semprius can "print" semiconductors on various surfaces
Stem cell-focused Aldagen raises $1.1M in funding
The Durham-based company recently withdrew plans for an $80 million stock offering.
A purified STEM cell
CIA pours more money into Durham solar tech startup
The secret sauce at Semprius draws more money from the "Wizards of Langley" venture arm as well as Siemens and Durham-based Intersouth in its latest $20 million capital fund raiser. So what can the CIA do with advanced solar power?
Might Semprius someday power a CIA drone?
Solar power startup Semprius raises $20M, looks for $10M more
The Durham-based company, which recently sold a 16-percent interest to Siemens Energy, discloses the funding in a regulatory filing. It's the latest in a streak of good news for the firm and its investors, which include Durham-based Intersouth Partners.
An illustration of Semprius' transfer process
Venture capitalists fear future as ranks of 'walking dead' grow
The VC industry is already shrinking, and the lack of initial public offerings, or IPOs, as an "exit" for their investments is a global threat to the survivors. More than 80 percent of VCs say they are fretting. The number of "walking dead" firms - those not making investments - is soaring, another report says.
PeopleMatter raises $7.2 million in VC funding
Leading talent management provider for the service industry seizes new opportunities to accelerate growth and fuel active product pipeline with second round funding led by Noro-Moseley Partners.
PeopleMatter
Stem cell firm Aldagen withdraws planned $80.5M IPO
The Durham-based life science company cites "market conditions" as the reason for the pullback. It's the second time that the company, which is backed by Triangle venture firms Intersouth and Aurora, has cancelled an IPO.
A purified stem cell
As SciQuest investors cash out, its CEO rings Nasdaq opening bell
The Cary-based company is also seeking to raise another $15 million through stock sale. Investors are looking to sell another $50 million in SciQuest holdings.
Stphen Wiehe claps after opening Nasdaq on Friday.
Former Embrex CEO to chair Advanced Animal Diagonstics board
The venture-backed startup, which recently closed on $11.3 million in funding, names two of its investors and CEO to board.
Durham animal health startup raises $11M in funding
Advanced Animal Diagnostics closes on its second round of financing with Intersouth Partners and Novartis Venture Funds leading the round.
Good news for entrepreneurs: Venture deals rebound in NC
New data shows North Carolina investments rose back to pre-recession levels in 2010. "What's really encouraging is that North Carolina so dramatically outpaced the rest of the country in its recovery back to pre-recession investment levels," says Intersouth Partners' Jimmy Rosen.
